Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics : Vol. 2: Molecular Mechanisms

Discusses AD at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. Presents new therapeutics for neurodegenerative disorders, behavioral intervention.

As research continues to uncover the complex causes of Alzheimer’s disease, a deeper understanding of its cellular and molecular mechanisms is essential for developing effective therapies. Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics, a two volume set, provides a comprehensive examination of the processes driving disease onset and progression, bringing together leading experts to illuminate key pathways, therapeutic targets, and emerging treatment strategies. Volume 1: Cellular Mechanisms explores the cellular mechanisms underlying Alzheimer’s disease—such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation—while highlighting their therapeutic implications, including personalized medicine, blood–brain barrier dynamics, and micro RNA-based approaches. Volume 2: Molecular Mechanisms examines AD at the molecular level—covering protein aggregation, cellular dysfunction, and neuroinflammation—while integrating emerging therapies, personalized approaches, and global research efforts to bridge fundamental mechanisms with clinical applications.